Gene therapies must become miracles of medicine

Otherwise they might end up a niche treatment for a small number of patients in rich countries | Briefing

Related Keywords

Switzerland ,Japan ,Germany ,Berkeley ,California ,United States ,Netherlands ,United Kingdom ,To Stat ,Midi Pyrées ,France ,Massachusetts ,Boston ,Cambridge ,Cambridgeshire ,San Francisco ,Britain ,America ,French ,Japanese ,American ,Dutch ,Swiss ,Jay Bradner ,Nicole Paulk ,Janet Lambert ,Fyodor Urnov ,Oxford Astrazeneca ,Bernhardt Zeiher ,David Lillicrap ,Mike Mccune ,Ethan Ralston ,Karen Pignet Aiach ,James Wilson ,Jesse Gelsinger ,University Of California ,Amicus Therapeutics ,Queen University ,Centre For Biomedical Innovation In Cambridge ,Melinda Gates Foundation ,Novartis ,Pfizer ,Vertex Pharmaceuticals ,Aspen Institute ,Novartis Institutes For Biomedical Research ,Blue Cross Shield Association ,Drug Administration ,Boston Consulting Group ,University Of Pennsylvania ,European Medicines Agency ,Alliance For Regenerative Medicine ,Leber Hereditary Optic Neuropathy ,Regenerative Medicine ,Biomedical Innovation ,Solid Biosciences ,August Novartis ,Novartis Institutes ,Global Blood Therapies ,